Dr Reddy's Laboratories Ltd
F:RDDA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
D
|
Dr Reddy's Laboratories Ltd
F:RDDA
|
IN |
|
S
|
Stroeer SE & Co KgaA
F:SAX
|
DE |
|
R
|
Realty Income Corp
XMUN:RY6
|
US |
|
Boot Barn Holdings Inc
NYSE:BOOT
|
US |
|
Equifax Inc
NYSE:EFX
|
US |
|
Xiaomi Corp
F:3CP1
|
CN |
|
A
|
Anglo American Platinum Ltd
XMUN:RPHA
|
ZA |
|
Cimpress PLC
NASDAQ:CMPR
|
IE |
|
V
|
Vertex Pharmaceuticals Inc
DUS:VX1
|
US |
|
C
|
China Construction Bank Corp
XMUN:C6T
|
CN |
|
S
|
Siemens AG
SIX:SIN
|
DE |
|
S
|
Schroders PLC
F:PYXB
|
UK |
|
L
|
Longfor Group Holdings Ltd
XMUN:RLF
|
CN |
|
C
|
Canadian National Railway Co
XMUN:CY2
|
CA |
|
Securitas AB
OTC:SCTBF
|
SE |
|
A
|
American Electric Power Company Inc
XBER:AEP
|
US |
|
TOC Co Ltd
F:T3O
|
JP |
|
S
|
Stryker Corp
XBER:SYK
|
US |
|
C
|
China Taiping Insurance Holdings Co Ltd
F:HIUC
|
HK |
|
Grupo Aeroportuario del Sureste SAB de CV
BMV:ASURB
|
MX |
|
S
|
Swire Properties Ltd
HKEX:1972
|
HK |
|
A
|
Anglo American Platinum Ltd
XBER:RPHA
|
ZA |
|
C
|
China Lilang Ltd
F:5LX
|
CN |
|
K
|
Kohls Corp
F:KHP
|
US |
Wall St Price Targets
RDDA Price Targets Summary
Dr Reddy's Laboratories Ltd
According to Wall Street analysts, the average 1-year price target for RDDA is 11.86 EUR with a low forecast of 9.09 EUR and a high forecast of 15.9 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RDDA's stock price target?
Price Target
11.86
EUR
According to Wall Street analysts, the average 1-year price target for RDDA is 11.86 EUR with a low forecast of 9.09 EUR and a high forecast of 15.9 EUR.
What is the Revenue forecast for Dr Reddy's Laboratories Ltd?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 4 years is 8%.
What is the Gross Profit forecast for Dr Reddy's Laboratories Ltd?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 8%. The projected CAGR for the next 4 years is 6%.
What is the Operating Income forecast for Dr Reddy's Laboratories Ltd?
Projected CAGR
18%
Over the last 13 years, the compound annual growth rate for Operating Income has been 6%. The projected CAGR for the next 4 years is 18%.
What is the Pre-Tax Income forecast for Dr Reddy's Laboratories Ltd?
Projected CAGR
17%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 7%. The projected CAGR for the next 2 years is 17%.
What is the Net Income forecast for Dr Reddy's Laboratories Ltd?
Projected CAGR
16%
Over the last 13 years, the compound annual growth rate for Net Income has been 8%. The projected CAGR for the next 4 years is 16%.
